Case Study | Module 3 Regulatory Compliance of full portfolio

August 2, 2023

Have a look at a recent success story of how Asphalion helped an international European pharmaceutical company with a wide portfolio of medicinal products and important discrepancies between the registration documentation and the quality/manufacturing documentation, aiming to achieve full M3 dossier compliance.

Thanks to our extensive track record of over 20 years at Asphalion we can assist you to choose the right strategy, optmizing costs and enhancing time-to-market, and with all other kind of activities and projects.

Case Study Asphalion_Marketing authorization expansion in Europe

For further information you can contact us at: [email protected]

Search News & Events

  • Filter by category

Share

Related news and events

EVENT | DIA RAPS Regulatory Policy Forum

Many key takeaways and highlights from the DIA RAPs Regulatory Policy Forum!! Capitalizing on the success of their joint collaboration this past January for 2024 Combination Products in the EU, DIA and the Regulatory Affairs Professionals Society (RAPS) are coming together once again to produce the 2024 Regulatory Policy Forum.
Designed specifically for regulatory policy leaders, senior decision makers, and regulators across the pharmaceutical community, this summit will explore the new EU pharmaceutical legislation and how it will shape the future of the pharmaceutical arena—including research, development and manufacturing—in Europe for decades to come.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting